Stoma

Prevalence

10.0 / 100K

Incidence

6.1 / 100K/yr

243 drugs in development·62 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
danyelza	Y-mAbs Therapeutics, Inc. (YMAB)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
famotidine	DR REDDYS LABORATORIES LTD (RDY)
Unituxin	UNITED THERAPEUTICS Corp (UTHR)

Phase 3(44)

Drug	Company
[177Lu]Lu-DOTA-TATE	Novartis AG (NVS)
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 & AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 and AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Apremilast	Crinetics Pharmaceuticals, Inc. (CRNX)
Ceritinib	ENANTA PHARMACEUTICALS INC (ENTA)
Dasatinib	Filana Therapeutics Inc. (FLNA)
Dinituximab	Black Diamond Therapeutics, Inc. (BDTX)
Dinutuximab	Black Diamond Therapeutics, Inc. (BDTX)
Dinutuximab	PTC THERAPEUTICS, INC. (PTCT)
Dinutuximab	ENANTA PHARMACEUTICALS INC (ENTA)
Dinutuximab with Chemotherapy	UNITED THERAPEUTICS Corp (UTHR)
Domvanalimab	Arcus Biosciences, Inc. (RCUS)
Eflornithine Hydrochloride	Filana Therapeutics Inc. (FLNA)
etoposide	Black Diamond Therapeutics, Inc. (BDTX)
Etoposide	Assertio Holdings, Inc. (ASRT)
Etoposide	PTC THERAPEUTICS, INC. (PTCT)
Etoposide phosphate	Black Diamond Therapeutics, Inc. (BDTX)
Filgrastim	Assertio Holdings, Inc. (ASRT)
ict-107	EOM Pharmaceutical Holdings, Inc. (IMUC)
Isotretinoin	Black Diamond Therapeutics, Inc. (BDTX)
Isotretinoin	Filana Therapeutics Inc. (FLNA)
Isotretinoin	PTC THERAPEUTICS, INC. (PTCT)
Isotretinoin	ENANTA PHARMACEUTICALS INC (ENTA)
lomustine	Edison Oncology Holding Corp (EOHC)
lomustine	CG Oncology, Inc. (CGON)
Lomustine	Filana Therapeutics Inc. (FLNA)
Lomustine	PTC THERAPEUTICS, INC. (PTCT)
Lomustine	Merus N.V. (MRUS)
Melphalan	PTC THERAPEUTICS, INC. (PTCT)
Melphalan	ENANTA PHARMACEUTICALS INC (ENTA)
Melphalan	Black Diamond Therapeutics, Inc. (BDTX)
pemigatinib	Incyte Corp. (INCY)
Sodium Thiosulfate	Filana Therapeutics Inc. (FLNA)
temozolomide	Black Diamond Therapeutics, Inc. (BDTX)
Temozolomide	CG Oncology, Inc. (CGON)
Temozolomide	Merus N.V. (MRUS)
Temozolomide Oral Product	Black Diamond Therapeutics, Inc. (BDTX)
Thiotepa	Black Diamond Therapeutics, Inc. (BDTX)
Thiotepa	PTC THERAPEUTICS, INC. (PTCT)
Topotecan	Black Diamond Therapeutics, Inc. (BDTX)
Vincristine	Assertio Holdings, Inc. (ASRT)
Vincristine	Black Diamond Therapeutics, Inc. (BDTX)
Zimberelimab	Arcus Biosciences, Inc. (RCUS)

Phase 2(97)

Drug	Company
azixa	IMMUNE PHARMACEUTICALS INC (IMNP)
BDTX-1535	Black Diamond Therapeutics, Inc. (BDTX)
Berubicin	CNS Pharmaceuticals, Inc. (CNSP)
Celecoxib	AIM ImmunoTech Inc. (AIM)
Celecoxib	Black Diamond Therapeutics, Inc. (BDTX)
cemiplimab	Alaunos Therapeutics, Inc. (TCRT)
Ceritinib	Filana Therapeutics Inc. (FLNA)
Cytarabine	AIM ImmunoTech Inc. (AIM)
Cytoxan	PTC THERAPEUTICS, INC. (PTCT)
Cytoxan	ENANTA PHARMACEUTICALS INC (ENTA)
Cytoxan	Merus N.V. (MRUS)
Cytoxan	Filana Therapeutics Inc. (FLNA)
DANYELZA	Filana Therapeutics Inc. (FLNA)
DANYELZA	Merus N.V. (MRUS)
DANYELZA	PTC THERAPEUTICS, INC. (PTCT)
DANYELZA	ENANTA PHARMACEUTICALS INC (ENTA)
DFMO	ENANTA PHARMACEUTICALS INC (ENTA)
DFMO	Filana Therapeutics Inc. (FLNA)
Dinutuximab	UNITED THERAPEUTICS Corp (UTHR)
Dinutuximab	Merus N.V. (MRUS)
DOC1021	Black Diamond Therapeutics, Inc. (BDTX)
Eflornithine Hydrochloride	Black Diamond Therapeutics, Inc. (BDTX)
Eflornithine Hydrochloride	PTC THERAPEUTICS, INC. (PTCT)
Etoposide	Structure Therapeutics Inc. (GPCR)
Etoposide	ENANTA PHARMACEUTICALS INC (ENTA)
Etoposide	AIM ImmunoTech Inc. (AIM)
etoposide phosphate	AIM ImmunoTech Inc. (AIM)
Etoposide Phosphate	ENANTA PHARMACEUTICALS INC (ENTA)
Fenofibric acid	AIM ImmunoTech Inc. (AIM)
Fenofibric acid	Black Diamond Therapeutics, Inc. (BDTX)
FLOT	Arcus Biosciences, Inc. (RCUS)
GM-CSF	UNITED THERAPEUTICS Corp (UTHR)
gm-csf + naxitamab	Y-mAbs Therapeutics, Inc. (YMAB)
GM-CSF + Naxitamab	Filana Therapeutics Inc. (FLNA)
hu14.18k322a	GH Research PLC (GHRS)
hu14.18K322A	PTC THERAPEUTICS, INC. (PTCT)
hu14.18K322A	Filana Therapeutics Inc. (FLNA)
hu14.18K322A	CG Oncology, Inc. (CGON)
hu14.18K322A	Black Diamond Therapeutics, Inc. (BDTX)
ict-121	EOM Pharmaceutical Holdings, Inc. (IMUC)
Ifosfamide	Filana Therapeutics Inc. (FLNA)
Ifosfamide	ENANTA PHARMACEUTICALS INC (ENTA)
inb-400	IN8BIO, INC. (INAB)
ino-5401	INOVIO PHARMACEUTICALS, INC. (INO)
lomustine	CNS Pharmaceuticals, Inc. (CNSP)
Lomustine	ENANTA PHARMACEUTICALS INC (ENTA)
Lomustine	ADMA BIOLOGICS, INC. (ADMA)
lsta1	LISATA THERAPEUTICS, INC. (LSTA)
Montanide ISA 51 VG	Black Diamond Therapeutics, Inc. (BDTX)
N-803	ENANTA PHARMACEUTICALS INC (ENTA)
n803	GH Research PLC (GHRS)
N803	PTC THERAPEUTICS, INC. (PTCT)
N803	Filana Therapeutics Inc. (FLNA)
N803	CG Oncology, Inc. (CGON)
N803	Black Diamond Therapeutics, Inc. (BDTX)
Neoadjuvant Chemotherapy	UNITED THERAPEUTICS Corp (UTHR)
OPT-821	Crinetics Pharmaceuticals, Inc. (CRNX)
PD-L1 t-haNK	ENANTA PHARMACEUTICALS INC (ENTA)
PD-L1 t-haNK	ImmunityBio, Inc. (IBRX)
Pegfilgrastim	Assertio Holdings, Inc. (ASRT)
Radiation	UNITED THERAPEUTICS Corp (UTHR)
Relatlimab	ENANTA PHARMACEUTICALS INC (ENTA)
reyobiq	PLUS THERAPEUTICS Inc. (PSTV)
ropidoxuridine	Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
sargramostim	GH Research PLC (GHRS)
Sargramostim	PTC THERAPEUTICS, INC. (PTCT)
Sargramostim	UNITED THERAPEUTICS Corp (UTHR)
Sargramostim	Merus N.V. (MRUS)
Sargramostim	ENANTA PHARMACEUTICALS INC (ENTA)
Sargramostim	Black Diamond Therapeutics, Inc. (BDTX)
Sargramostim	CG Oncology, Inc. (CGON)
Sargramostim	Filana Therapeutics Inc. (FLNA)
silevertinib	Black Diamond Therapeutics, Inc. (BDTX)
silevertinib in combination with temozolomide	Black Diamond Therapeutics, Inc. (BDTX)
sl-701	STEMLINE THERAPEUTICS INC (STML)
SVN53-67/M57-KLH Peptide Vaccine	Black Diamond Therapeutics, Inc. (BDTX)
Temozolomide	Jazz Pharmaceuticals plc (JAZZ)
Temozolomide	Filana Therapeutics Inc. (FLNA)
Temozolomide	BioNTech SE (BNTX)
Thalidomide	AIM ImmunoTech Inc. (AIM)
Thalidomide	Black Diamond Therapeutics, Inc. (BDTX)
Topotecan	Filana Therapeutics Inc. (FLNA)
Topotecan	Assertio Holdings, Inc. (ASRT)
Topotecan	ENANTA PHARMACEUTICALS INC (ENTA)
Topotecan	PTC THERAPEUTICS, INC. (PTCT)
Topotecan	Structure Therapeutics Inc. (GPCR)
trc102	Tracon Pharmaceuticals, Inc. (TCON)
TTRNA-DCs	UNITED THERAPEUTICS Corp (UTHR)
TTRNA-xALT	UNITED THERAPEUTICS Corp (UTHR)
veldona	Ainos Inc. (AIMD)
Vincristine	ENANTA PHARMACEUTICALS INC (ENTA)
Vincristine Sulfate	ENANTA PHARMACEUTICALS INC (ENTA)
Vincristine Sulfate Liposome	ENANTA PHARMACEUTICALS INC (ENTA)
vorinostat	ENANTA PHARMACEUTICALS INC (ENTA)
Vorinostat	UNITED THERAPEUTICS Corp (UTHR)
Vorinostat	Filana Therapeutics Inc. (FLNA)
wp1066	Moleculin Biotech, Inc. (MBRX)

Phase 1(53)

Drug	Company
[177lu]lu-dota-tate	Novartis AG (NVS)
[177Lu]Lu-DOTA-TATE	PTC THERAPEUTICS, INC. (PTCT)
[177lu]lu-neob	Novartis AG (NVS)
[68ga]ga-dota-tate	Novartis AG (NVS)
[68Ga]Ga-DOTA-TATE	PTC THERAPEUTICS, INC. (PTCT)
[68ga]ga-neob	Novartis AG (NVS)
ABBV-155	Black Diamond Therapeutics, Inc. (BDTX)
ABBV-155	Merus N.V. (MRUS)
ABBV-155	PTC THERAPEUTICS, INC. (PTCT)
ABBV-637	PTC THERAPEUTICS, INC. (PTCT)
ABBV-637	Merus N.V. (MRUS)
ABBV-637	Black Diamond Therapeutics, Inc. (BDTX)
ad-rts-hil-12	Alaunos Therapeutics, Inc. (TCRT)
AUTO6NG	Autolus Therapeutics plc (AUTL)
Cemiplimab	Actinium Pharmaceuticals, Inc. (ATNM)
CV09050101 mRNA vaccine 100 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine 12 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine 25 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine 50 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine 6 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine RDE 100 μg	CureVac N.V. (CVAC)
Dinituximab	PTC THERAPEUTICS, INC. (PTCT)
ERAS-801	PTC THERAPEUTICS, INC. (PTCT)
ERAS-801	Merus N.V. (MRUS)
ERAS-801	Black Diamond Therapeutics, Inc. (BDTX)
Fludarabine	UNITED THERAPEUTICS Corp (UTHR)
group a standard-of-care backbone therapy	National Research Corporation Common Stock (Delaware) (NRC)
immunization	Black Diamond Therapeutics, Inc. (BDTX)
inb-200	IN8BIO, INC. (INAB)
kros 201	Kairos Pharma, LTD. (KAPA)
kur-501	Athenex, Inc. (ATNX)
LY3214996	ELI LILLY & Co (LLY)
ly3295668 erbumine	ELI LILLY & Co (LLY)
mb-101	Fortress Biotech Inc. (FBIO)
mb-101	Fortress Biotech Inc. (FBIO)
mb-101	MUSTANG BIO, INC. (MBIO)
mb-108	Fortress Biotech Inc. (FBIO)
mb-109	MUSTANG BIO, INC. (MBIO)
Mebendazole (improved formulation)	Bullfrog AI Holdings Inc. (BFRG)
Potassium Iodide	UNITED THERAPEUTICS Corp (UTHR)
pritumumab	Nascent Biotech Inc. (NBIO)
rhIL-15	PTC THERAPEUTICS, INC. (PTCT)
rhIL-15	Black Diamond Therapeutics, Inc. (BDTX)
Selinexor	Black Diamond Therapeutics, Inc. (BDTX)
Selinexor	PTC THERAPEUTICS, INC. (PTCT)
Selinexor	Merus N.V. (MRUS)
ST101	KYNTRA BIO INC. (KYNB)
Temozolomide	KYNTRA BIO INC. (KYNB)
Thiotepa	ENANTA PHARMACEUTICALS INC (ENTA)
TN-TC11G	Black Diamond Therapeutics, Inc. (BDTX)
Topotecan	ELI LILLY & Co (LLY)
veledimex	Alaunos Therapeutics, Inc. (TCRT)
Vincristine	Structure Therapeutics Inc. (GPCR)

Preclinical(8)

Drug	Company
aktx-102	Akari Therapeutics Plc (AKTX)
BF-223	Bullfrog AI Holdings Inc. (BFRG)
chi3l1 bsabs	Ocean Biomedical, Inc. (OCEA)
chi3l1 mab	Ocean Biomedical, Inc. (OCEA)
gtb-5550	GT Biopharma, Inc. (GTBP)
mapkapk2 inhibitor	METASTAT, INC. (MTST)
oncr-719	Oncorus, Inc. (ONCR)
TPI 287	CNS Pharmaceuticals, Inc. (CNSP)

Unknown(3)

Drug	Company
eflornithine HCl	ENANTA PHARMACEUTICALS INC (ENTA)
eflornithine HCl	Filana Therapeutics Inc. (FLNA)
VELDONA (feline chronic gingivostomatitis - FCGS)	Ainos Inc. (AIMD)

BLA Filed(1)

Drug	Company
dcvax-l	NORTHWEST BIOTHERAPEUTICS INC (NWBO)

Phase 1/Phase 2(11)

Drug	Company
[68Ga]Ga-DOTA-TATE	Novartis AG (NVS)
allogeneic genetically modified gamma-delta t cells	IN8BIO, INC. (INAB)
autologous genetically modified gamma-delta t cells	IN8BIO, INC. (INAB)
cemiplimab	INOVIO PHARMACEUTICALS, INC. (INO)
elraglusib	ACTUATE THERAPEUTICS, INC. (ACTU)
ino-9012	INOVIO PHARMACEUTICALS, INC. (INO)
lomustine	VBI VACCINES INC/BC (VBIV)
lp-184	Lantern Pharma Inc. (LTRN)
perillyl alcohol	NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
temferon	Genenta Science S.p.A. (GNTA)
vbi-1901	VBI VACCINES INC/BC (VBIV)

Phase 2/Phase 3(9)

Drug	Company
adi-peg 20	GH Research PLC (GHRS)
azd1390	GH Research PLC (GHRS)
lomustine	GH Research PLC (GHRS)
mn-166	MEDICINOVA INC (MNOV)
paxalisib	GH Research PLC (GHRS)
tinostamustine	GH Research PLC (GHRS)
troriluzole	GH Research PLC (GHRS)
val-083	GH Research PLC (GHRS)
vt1021	GH Research PLC (GHRS)

Phase 4(11)

Drug	Company
Dinituximab	Filana Therapeutics Inc. (FLNA)
Dinutuximab	Filana Therapeutics Inc. (FLNA)
Induction	Filana Therapeutics Inc. (FLNA)
Induction	Merus N.V. (MRUS)
Induction	Structure Therapeutics Inc. (GPCR)
Single Cycle Intensive Chemotherapy	Structure Therapeutics Inc. (GPCR)
Single Cycle Intensive Chemotherapy	Filana Therapeutics Inc. (FLNA)
Tandem 3 Cycle Intensive Chemotherapy	Filana Therapeutics Inc. (FLNA)
Tandem 3 Cycle Intensive Chemotherapy	Structure Therapeutics Inc. (GPCR)
Vincristine	Filana Therapeutics Inc. (FLNA)
Vincristine Sulfate Liposome	Filana Therapeutics Inc. (FLNA)

Compare drugs

carmustine vs cyclophosphamide carmustine vs danyelza carmustine vs doxorubicin

Frequently asked questions

How many drugs are in development for Stoma?

BioSniper tracks 243 drugs in development for Stoma across 62 companies.

How many clinical trials target Stoma?

There are 1 clinical trial targeting Stoma tracked by BioSniper.

What is the prevalence of Stoma?

The estimated prevalence of Stoma is approximately 10.0 per 100,000 population.

Deep-dive into Stoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis